Form 4 · Filed Nov 4, 2026, 07:56 PM UTC
VIR/Vir Biotechnology, Inc.
de Verneuil Vanina — EVP, General Counsel, Corp Sec
AI Thesis
No AI thesis for this filing. Theses are generated only for high-signal filings (e.g. cluster buys and large discretionary purchases), by a local model (gemma4:e2b-it-qat) on this server; if this filing qualifies it will appear once processed.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
2 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Nov 3, 2026 | S | sell | 2,407 | $11 | $26,718 | 110,193 |
| Nov 2, 2026 | S | sell | 1,343 | $11 | $15,222 | 112,600 |
Source: SEC EDGAR raw filing ↗ · Accession 0001628280-26-070025